ARTICLE | Clinical News
Evolutec preclinical data
March 5, 2007 8:00 AM UTC
In a model of asthma, inhaled rEV576 significantly reduced airway hyper-responsiveness. The complement 5 (C5) inhibitor also reduced the number of eosinophils in the bronchoalveolar lavage fluid, whi...